Health Canada highlights safety information issued in France

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2003年 / 945卷 / 1期

关键词：

Amifostine; Diethylstilbestrol; Cutaneous Reaction; Internet Document; Clear Cell Adenocarcinoma;

D O I：

10.2165/00128415-200309450-00004

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] Health Canada highlights statin safety information
Reactions Weekly, 2005, 1062 (1) : 3 - 3
[2] Safety information on gadodiamide issued in Canada
Reactions Weekly, 2006, 1111 (1) : 3 - 3
[3] `Permax' safety information issued in Canada
Reactions Weekly, 2003, 949 (1) : 2 - 2
[4] AstraZeneca Canada Inc., in consultation with Health Canada, has issued important safety information on PULMICORT TURBUHALER
Reactions Weekly, 2012, 1413 (1) : 3 - 3
[5] Quality and Quantity of Information in Summary Basis of Decision Documents Issued by Health Canada
Habibi, Roojin
Lexchin, Joel
PLOS ONE, 2014, 9 (03):
[6] New Avastin safety info issued in Canada
Reactions Weekly, 2007, 1157 (1) : 2 - 2
[7] Tamoxifen: Health Canada issues safety information
Reactions Weekly, 2002, 929 (1) : 2 - 2
[8] Health Canada has issued both a Public Communication and a 'Dear Healthcare Professional' letter advising of updated safety information for Invirase [saquinavir]
Reactions Weekly, 2010, 1327 (1) : 6 - 6
[9] Droperidol: cardiovascular warnings issued by Health Canada
Reactions Weekly, 2002, 890 (1) : 3 - 3
[10] Health Canada issues safety information on bone cements
Reactions Weekly, 2007, 1139 (1) : 2 - 2

← 1 2 3 4 5 →